Excelsior Sciences raises $95M for small molecule drug discovery, manufacturingnews2025-12-03T13:00:11+00:00December 3rd, 2025|Endpoints News|
Bristol Myers pushes back Cobenfy readout after trial site ‘irregularities’news2025-12-03T12:41:17+00:00December 3rd, 2025|Endpoints News|
Eurozone private sector momentum rallies in Novembernews2025-12-03T12:25:00+00:00December 3rd, 2025|Independent Commodity Intelligence Services (ICIS)|
Updated: Pharvaris’ hereditary angioedema drug gets Phase 3 winnews2025-12-03T12:20:48+00:00December 3rd, 2025|Endpoints News|
Tampa ammonia contract price settles at rollover for December as supply tightness easesnews2025-12-03T12:13:00+00:00December 3rd, 2025|Independent Commodity Intelligence Services (ICIS)|
Cosmo Pharmaceuticals’ shares rise after Phase 3 win in male pattern hair lossnews2025-12-03T12:11:32+00:00December 3rd, 2025|Endpoints News|
CRUDE OUTLOOK: Crude benchmarks expected to decline in Q1 amid supply glut worriesnews2025-12-03T12:09:00+00:00December 3rd, 2025|Independent Commodity Intelligence Services (ICIS)|
Europe PMMA price falls in Q4news2025-12-03T11:58:00+00:00December 3rd, 2025|Independent Commodity Intelligence Services (ICIS)|
TTF discount to Asia price widens on reduced weather risk, rising LNG shipping ratesnews2025-12-03T11:47:00+00:00December 3rd, 2025|Independent Commodity Intelligence Services (ICIS)|
China domestic MLLDPE prices weighed down by ample supply, poor demandnews2025-12-03T11:39:00+00:00December 3rd, 2025|Independent Commodity Intelligence Services (ICIS)|
